Hongxia Wang

902 total citations
53 papers, 601 citations indexed

About

Hongxia Wang is a scholar working on Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hongxia Wang has authored 53 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Pathology and Forensic Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hongxia Wang's work include Obstructive Sleep Apnea Research (3 papers), Heart Failure Treatment and Management (3 papers) and Cancer-related molecular mechanisms research (3 papers). Hongxia Wang is often cited by papers focused on Obstructive Sleep Apnea Research (3 papers), Heart Failure Treatment and Management (3 papers) and Cancer-related molecular mechanisms research (3 papers). Hongxia Wang collaborates with scholars based in China, United States and Hong Kong. Hongxia Wang's co-authors include Changfeng Fu, Zhuo Zhang, Manxia Wang, Yang Luo, Jing Sun, Yi Liu, Zhenyu Wang, Zhenyu Wang, Yi Liu and Tamara Escajadillo and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Psychology and Medicine.

In The Last Decade

Hongxia Wang

48 papers receiving 590 citations

Peers

Hongxia Wang
Haimin Xu China
Luwen Zhu China
Sai Zhang China
Damir Nizamutdinov United States
Dong Hwan Yun South Korea
Hongxia Wang
Citations per year, relative to Hongxia Wang Hongxia Wang (= 1×) peers Mayuko Kadono

Countries citing papers authored by Hongxia Wang

Since Specialization
Citations

This map shows the geographic impact of Hongxia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Wang more than expected).

Fields of papers citing papers by Hongxia Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Wang. The network helps show where Hongxia Wang may publish in the future.

Co-authorship network of co-authors of Hongxia Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxia Wang. A scholar is included among the top collaborators of Hongxia Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxia Wang. Hongxia Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hongxia, Bei Zhang, Yingxin Zhao, et al.. (2025). Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review. Frontiers in Oncology. 14. 1480880–1480880.
2.
Li, Chong, et al.. (2025). Pathogenesis of pepsin-induced gastroesophageal reflux disease with advanced diagnostic tools and therapeutic implications. Frontiers in Medicine. 12. 1516335–1516335. 1 indexed citations
3.
Liu, Chunhua, Min Tan, Jun Li, et al.. (2025). CD36-mediated fatty acid metabolic reprogramming activates synovial fibroblasts and promotes rheumatoid arthritis progression. International Immunopharmacology. 167. 115594–115594.
4.
Chen, Junjie, Shu‐Yi Yin, Sheng Xia, et al.. (2024). A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study. Journal of Hepatocellular Carcinoma. Volume 11. 191–206. 8 indexed citations
5.
Liu, Jun, Ning Li, Weiyi Huang, et al.. (2024). An open-label, placebo-controlled, randomized phase II trial of camrelizumab combined with or without apatinib or capecitabine in the treatment of previously treated advanced pancreatic cancer.. Journal of Clinical Oncology. 42(16_suppl). e16324–e16324. 1 indexed citations
8.
Zhang, Bei, et al.. (2022). Chidamide and Decitabine in Combination with a HAG Priming Regimen for Acute Myeloid Leukemia with TP53 Mutation. Okayama University Scientific Achievement Repository (Okayama University). 3 indexed citations
9.
Wang, Hongxia, Jing Wang, Nan Wang, et al.. (2022). Modified Iron Deposition in Nigrosomes by Pharmacotherapy for the Management of Parkinson’s Disease. Frontiers in Molecular Biosciences. 9. 908298–908298. 5 indexed citations
10.
Wang, Hongxia, et al.. (2022). Gray-White Matter Ratio at the Level of the Basal Ganglia as a Predictor of Neurologic Outcomes in Cardiac Arrest Survivors: A Literature Review. Frontiers in Medicine. 9. 847089–847089. 7 indexed citations
11.
Yan, Ruifang, Zhong Li, Gaiyun Zhang, et al.. (2022). Evaluation of Amide Proton Transfer-Weighted Imaging for Risk Factors in Stage I Endometrial Cancer: A Comparison With Diffusion-Weighted Imaging and Diffusion Kurtosis Imaging. Frontiers in Oncology. 12. 876120–876120. 8 indexed citations
12.
Wang, Hongxia, et al.. (2021). Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-511. Clinics and Research in Hepatology and Gastroenterology. 45(2). 101648–101648. 10 indexed citations
13.
Chen, Yan, et al.. (2021). Peri-operative echocardiography for lung transplantation in a critical patient with COVID-19. Cardiovascular journal of South Africa. 32(6). 57–59. 1 indexed citations
14.
Wang, Hongxia, et al.. (2021). Use of the pictorial Sleepiness and Sleep Apnoea Scale in Chinese patients with suspected obstructive sleep apnoea syndrome. Journal of Thoracic Disease. 13(10). 6071–6081. 1 indexed citations
15.
Jin, Aoming, Ming‐Hui Zhao, Yihong Sun, et al.. (2020). Normal range of serum potassium, prevalence of dyskalaemia and associated factors in Chinese older adults: a cross-sectional study. BMJ Open. 10(10). e039472–e039472. 7 indexed citations
16.
Wang, Hongxia, et al.. (2019). Giant left ventricular pseudoaneurysm: a rare acute complication of radiofrequency catheter ablation for premature ventricular contraction. Journal of Cardiothoracic Surgery. 14(1). 131–131. 2 indexed citations
17.
18.
Song, Pingping, Shanshan Li, Hao Wu, et al.. (2016). Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson’s disease. Protein & Cell. 7(2). 114–129. 81 indexed citations
19.
Cai, Xiaohong, Yupeng Xie, Xiucui Li, et al.. (2012). The prevalence and associated risk factors of sleep disorder-related symptoms in pregnant women in China. Sleep And Breathing. 17(3). 951–956. 31 indexed citations
20.
Luo, Yang, Changfeng Fu, Zhenyu Wang, et al.. (2012). Asiaticoside attenuates the effects of spinal cord injury through antioxidant and anti-inflammatory effects, and inhibition of the p38-MAPK mechanism. Molecular Medicine Reports. 12(6). 8294–8300. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026